Sai Mun Leong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sai Mun Leong has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Hui Wen Chua
Department of Pathology Yong Loo Lin School of Medicine National University of Singapore Singapore
2 shared publications- Karen Mei-Ling Tan
Institute for Human Development and Potential (IHDP), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
2 shared publications Steven Tucker
Tucker Medical Novena Specialist Center Singapore
2 shared publicationsEvelyn Siew-Chuan Koay
Department of Laboratory Medicine National University Hospital Singapore
1 shared publication- Evelyn Siew-Chuan Koay
Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, Singapore
1 shared publication - Evelyn Siew-Chuan Koay
Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
1 shared publication
Latest Publications
- Open Access
- 1 December 2017
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 63 (12) , 1899-1901
Improved Discrimination of Patients with Breast Cancer from Healthy Controls Using Paper-Based microRNA Expression Profiling of Plasma, Following Precipitation
To the Editor: Breast cancer is a frequently diagnosed solid tumor in women worldwide (1). MicroRNAs (miRNAs), small noncoding RNAs that regulate protein expression, are potential biomarkers in the diagnosis, prognosis, and prediction of response to treatment in breast cancer (2). We recently reported a paper-based method to extract miRNAs from plasma and circulating tumor cells (3). Here, we applied this method to plasma of patients with breast cancer and age- and gender-matched healthy controls, after treating the plasma with a commercial exosome isolation kit employing a nonspecific precipitation step; we compared the miRNA expression profiles from the plasma with and without the use of the precipitation method. After informed consent and institutional approval, we obtained peripheral blood samples from 9 patients with breast cancer and 9 healthy controls. Plasma was isolated by centrifugation at 3000 g for 10 min and stored at −80 °C. All plasma samples were visually inspected to exclude any discernible hemolysis. Then, 60 μL of Total Exosome Isolation reagent …
- 1 December 2017
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 63 (12) , 1899-1901
Open AccessImproved Discrimination of Patients with Breast Cancer from Healthy Controls Using Paper-Based microRNA Expression Profiling of Plasma, Following Precipitation
To the Editor: Breast cancer is a frequently diagnosed solid tumor in women worldwide (1). MicroRNAs (miRNAs), small noncoding RNAs that regulate protein expression, are potential biomarkers in the diagnosis, prognosis, and prediction of response to treatment in breast cancer (2). We recently reported a paper-based method to extract miRNAs from plasma and circulating tumor cells (3). Here, we applied this method to plasma of patients with breast cancer and age- and gender-matched healthy controls, after treating the plasma with a commercial exosome isolation kit employing a nonspecific precipitation step; we compared the miRNA expression profiles from the plasma with and without the use of the precipitation method. After informed consent and institutional approval, we obtained peripheral blood samples from 9 patients with breast cancer and 9 healthy controls. Plasma was isolated by centrifugation at 3000 g for 10 min and stored at −80 °C. All plasma samples were visually inspected to exclude any discernible hemolysis. Then, 60 μL of Total Exosome Isolation reagent …
- 1 March 2017
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 63 (3) , 731-741
Paper-Based MicroRNA Expression Profiling from Plasma and Circulating Tumor Cells
BACKGROUND: Molecular characterization of circulating tumor cells (CTCs) holds great promise for monitoring metastatic progression and characterizing metastatic disease. However, leukocyte and red blood cell contamination of routinely isolated CTCs makes CTC-specific molecular characterization extremely challenging. METHODS: Here we report the use of a paper-based medium for efficient extraction of microRNAs (miRNAs) from limited amounts of biological samples such as rare CTCs harvested from cancer patient blood. Specifically, we devised a workflow involving the use of Flinders Technology Associates (FTA)® Elute Card with a digital PCR-inspired “partitioning” method to extract and purify miRNAs from plasma and CTCs. RESULTS: We demonstrated the sensitivity of this method to detect miRNA expression from as few as 3 cancer cells spiked into human blood. Using this method, background miRNA expression was excluded from contaminating blood cells, and CTC-specific miRNA expression profiles were derived from breast and colorectal cancer patients. Plasma separated out during purification of CTCs could likewise be processed using the same paper-based method for miRNA detection, thereby maximizing the amount of patient-specific information that can be derived from a single blood draw. CONCLUSIONS: Overall, this paper-based extraction method enables an efficient, cost-effective workflow for maximized recovery of small RNAs from limited biological samples for downstream molecular analyses.
- 1 March 2017
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 63 (3) , 731-741
Paper-Based MicroRNA Expression Profiling from Plasma and Circulating Tumor Cells
BACKGROUND: Molecular characterization of circulating tumor cells (CTCs) holds great promise for monitoring metastatic progression and characterizing metastatic disease. However, leukocyte and red blood cell contamination of routinely isolated CTCs makes CTC-specific molecular characterization extremely challenging. METHODS: Here we report the use of a paper-based medium for efficient extraction of microRNAs (miRNAs) from limited amounts of biological samples such as rare CTCs harvested from cancer patient blood. Specifically, we devised a workflow involving the use of Flinders Technology Associates (FTA)® Elute Card with a digital PCR-inspired “partitioning” method to extract and purify miRNAs from plasma and CTCs. RESULTS: We demonstrated the sensitivity of this method to detect miRNA expression from as few as 3 cancer cells spiked into human blood. Using this method, background miRNA expression was excluded from contaminating blood cells, and CTC-specific miRNA expression profiles were derived from breast and colorectal cancer patients. Plasma separated out during purification of CTCs could likewise be processed using the same paper-based method for miRNA detection, thereby maximizing the amount of patient-specific information that can be derived from a single blood draw. CONCLUSIONS: Overall, this paper-based extraction method enables an efficient, cost-effective workflow for maximized recovery of small RNAs from limited biological samples for downstream molecular analyses.
- Open Access
- 1 January 2014
- Published by Elsevier in Leukemia Research Reports
- Vol. 3 (1) , 1-3
Prevalence of human endogenous retroviral element associates with Hodgkin's lymphoma incidence rates
- 1 January 2014
- Published by Elsevier in Leukemia Research Reports
- Vol. 3 (1) , 1-3
Open AccessPrevalence of human endogenous retroviral element associates with Hodgkin's lymphoma incidence rates